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Introduction: 
 Neonatal Abstinence Syndrome (NAS): 
neonatal withdrawal symptoms as a result 
of perinatal exposure to drugs, especially 
opiates, during pregnancy. 
 The rate of NAS has increased by 300% in 
the United States since the 1980’s1.   
 NAS treatment costs reaches as high as 
$112.6 million dollars per year, the majority 
of which was heavily influenced by 
extended hospital stays2. 
 Inpatient management using traditional 
strategies of care has led to a length of stay 
(LOS) range of 8-105 days with a median 
of 25-34 days3,4,5.  
 Oei et al 20016 found that inpatient LOS 
was decreased with the establishment of 
an outpatient clinic designed specifically for 
managing NAS patients.  
 The Neonatal Intensive Care Unit (NICU) at 
Lehigh Valley Health Network (LVHN) has 
adopted an outpatient methadone weaning 
protocol to treat NAS patients with the goal 
of limiting readmissions and decreasing 
inpatient length of stay. 
 
Plan: 
 Characterize patients with NAS, describe 
the current practices used at LVHN to treat 
infants with NAS, assess outcome 
variables at LVHN.  
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Do: 
 All term newborns (>37 weeks Estimated Gestational Age) 
at Lehigh Valley Hospital - Cedar Crest (LVH-CC) between 
1/1/2010 and 12/31/2014, admitted to LVH-CC, with an 
ICD-9 co-diagnosis of NAS at discharge were examined 
 Data collected via electronic medical records 
independently by at least two investigators  
 Exclusion criteria: treatment for NAS with medications 
other than opioids, an EGA less than 37 weeks at birth, 
congenital anomalies, iatrogenic NAS due to opiate 
administration while in the NICU, or infants of multiple 
gestation.  
Act / Conclusions: 
 The establishment of a clear management 
protocol for infants discharged from the NICU 
for NAS has many advantages.  It has been 
shown to increase opportunities for maternal-
infant pair bonding due to shorter hospital 
stays and increased rates of breastfeeding7.   
 Abdel-Latif et al. 20028 found that the role of 
breastfeeding in the outpatient management 
of NAS led to reduced withdrawal severity, 
delayed onset of NAS, and decreased need 
for pharmacologic treatment.  
 Backes et al 20129 calculated that patients in 
combined inpatient-to-outpatient management 
plan saved on average $13,817 in hospital 
costs per patient compared to a traditional, 
inpatient-only management strategy. 
 Next Steps: develop clinical pathway, 
compare cost savings 
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Study / Results: 
 
Figure 1: Inpatient Methadone Weaning Protocol. For 
infants with Finnegan Scores >8, additional steps are taken 
such as supplementation with high-calorie formula and 
vestibular stimulation. 
Table 1: Secondary Patient Outcomes. There were 56 patients 
identified that met inclusion/exclusion criteria. 
◄ Figure 2: Patient 
Characteristics. (A) Patient 
sex. (B) Patient race. There 
were no African-American 
patients. (C) Primary payer. 
(D) Oral fluids received. 
Figure 4: Readmissions Rate. There were two 30-day readmissions 
in this group, with only one related to NAS. The first patient was 
readmitted in 2013 for neonatal drug withdrawal symptoms 11 days 
after initial discharge and was later discharged 16 days after 
readmission.  
 
◄ Figure 3: Common 
Co-Diagnoses. Most 
diagnoses were not 
given to more than one 
patient.  
► Figure 3: Commonly 
Prescribed Medication. 
Morphine p.r.n. was needed 
in 71.43% of the patients. 
